Bisphosphonate-associated mandibular osteonecrosis
- PMID: 16687550
- PMCID: PMC7975761
Bisphosphonate-associated mandibular osteonecrosis
Abstract
A 66-year-old man with multiple myeloma treated with zoledronic acid, melphalan, and prednisone after a tooth extraction developed severe osteonecrosis of the mandible that was nonresponsive to antibiotic therapy. A CT scan showed innumerable fragmented sequestra in the mandible and some adjacent soft tissue fullness around the mandible. The association between the use of bisphosphonates and osteonecrosis of the jaw has been described only recently.
Figures
References
-
- American Cancer Society. Cancer: facts & figures 2002. Atlanta: American Cancer Society;2002. :4
-
- Kinney MKC, Swerdlow SH. Hematopoietic and lymphoid disorders. In: Barnes L, ed. Surgical pathology of the head and neck. New York: Marcel Dekker;2001. :1326–29
-
- Kyle RA, Rajkumar SV. Multiple myeloma. N Eng J Med 2004;351:1860–73 - PubMed
-
- Berensen JR, Rosen LS, Howell A, et al. Zoledronic acid reduces skeletal-related events in patients with osteolitic metastases. Cancer 2001;91:1191–200 - PubMed
-
- Magliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003;21:4253–54 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical